107
Views
11
CrossRef citations to date
0
Altmetric
CORRESPONDENCE

Rosuvastatin: A safe and effective treatment for dyslipidaemia associated with non-alcoholic steatohepatitis (NASH)

, Ph.D , M.D
Page 631 | Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maria C. Diakou, Evangelos N. Liberopoulos, Dimitri P. Mikhailidis, Epaminondas V. Tsianos, Andrew K. Burroughs & Moses S. Elisaf. (2007) Pharmacological treatment of non-alcoholic steatohepatitis: The current evidence. Scandinavian Journal of Gastroenterology 42:2, pages 139-147.
Read now
Mohamed H Ahmed, Meissa M Osman & Majed S Alokail. (2006) Statins and breast cancer: a smoking gun or guilt by association?. Expert Opinion on Drug Safety 5:5, pages 599-601.
Read now

Articles from other publishers (9)

Chrysoula Boutari, Panagiotis D. Pappas, Dimitrios Anastasilakis & Christos S. Mantzoros. (2022) Statins’ efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Clinical Nutrition 41:10, pages 2195-2206.
Crossref
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny & Ebtehal El-Demerdash. (2021) Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 271, pages 119220.
Crossref
Xu Li, Pujun Gao & Junqi Niu. (2019) Metabolic Comorbidities and Risk of Development and Severity of Drug-Induced Liver Injury. BioMed Research International 2019, pages 1-9.
Crossref
S. Gitto, G. Vitale, E. Villa & P. Andreone. (2015) Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future. Gastroenterology Research and Practice 2015, pages 1-14.
Crossref
Layli Eslami, Shahin Merat, Reza Malekzadeh, Siavosh Nasseri-Moghaddam & Hermineh Aramin. (2013) Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Cochrane Database of Systematic Reviews.
Crossref
Catherine J Cone, Amy M Bachyrycz & Glen H Murata. (2010) Hepatotoxicity Associated with Metformin Therapy in Treatment of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease. Annals of Pharmacotherapy 44:10, pages 1655-1659.
Crossref
Layli Eslami, Shahin Merat, Reza Malekzadeh, Siavosh Nasseri-Moghaddam & Hermineh Aramin. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Sweta Tandra & Raj Vuppalanchi. (2009) Use of statins in patients with liver disease. Current Treatment Options in Cardiovascular Medicine 11:4, pages 272-278.
Crossref
MH Ahmed & CD Byrne. (2007) Drug treatment and type 2 diabetes: the impact of liver disease. Practical Diabetes International 24:6, pages 318-323.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.